Bloomberg

Eric Balchunas marks the 50th anniversary of the first index fund, the Vanguard 500 Index Fund. It launched on August 31st, 1976 and eventually led the way for passive investing.

Brooks Cutright, portfolio manager at Hedgeye Asset Management, joins Scarlet Fu and Eric Balchunas on "Bloomberg ETF IQ." Index tracking funds have nearly $27 trillion tied to the S&P 500. This Friday the S&P 500 is set to announce who may be added or taken out of the index as part of a rebalancing. Thirty-six companies appear to qualify for entry, while more than 110 existing members no longer meet the index's market-cap hurdle.

Republican Congressman from Georgia Rich McCormick said that there's a lot of 'misinformation' around data centers and that communities with data centers will see improvements and lower property taxes from the outside investment. McCormick also weighed in on strikes between Iran and the US, saying he backed military involvement because the IRGC doesn't understand 'anything other than strength.'

Nick Panitsas, CIO of Farther Asset Management, joins Scarlet Fu and Eric Balchunas on "Bloomberg ETF IQ." They discuss 'Boomer candy' ETFs, the outperformance of Avantis US Small Cap Value ETF (Ticker: AVUV), and active ETFs.

Julie Gunts, global head of ETFs at AllianceBernstein, joins Scarlet Fu and Eric Balchunas on "Bloomberg ETF IQ."

Ben Hodges, a former commanding general for the US Army in Europe, said reports from the Trump administration on the conflict with Iran 'are not very closely connected to the truth on the ground.' General Hodges also said that he was 'encouraged' to hear reports that military leaders had pushed back on Defense Secretary Pete Hegseth and urged him to stop military extension of war with Iran.

Radiant has won a $750 million US Army contract to provide 15 portable nuclear microreactors under the Janus program. President and COO Tori Shivanandan discusses the technology behind the reactors, the military's push for resilient energy, and what Radiant needs to do next to scale production. She joins Ed Ludlow on "Bloomberg Tech."

The IA40 list from Madrona is back, spotlighting the private companies shaping the next phase of AI. Matt McIlwain, managing director at Madrona, explains how the list is assembled, why OpenAI, Anthropic and Databricks dominate AI fundraising, and how a successful Anthropic IPO could open the door for a new wave of public offerings in 2027. He joins Ed Ludlow on "Bloomberg Tech."

Nvidia makes another big bet on the future of AI with a $3.5 billion investment in MediaTek, as investors gear up for a potentially record-breaking Anthropic IPO. Forrester Research Founder and CEO George Colony weighs in on the AI boom, whether the hype is justified and what comes next. He speaks on Bloomberg Open Interest.

Eli Lilly & Co. plans to buy Merida Biosciences Inc. for as much as $2.88 billion in cash to expand in autoimmune and allergic diseases, part of an effort to build beyond the weight-loss and diabetes markets that made it the largest pharmaceutical company in the world. Lilly has been on a record spending spree, having announced more than $20 billion in deals so far in 2026. The drugmaker has been using the windfall from its Zepbound and Mounjaro shots to diversify its pipeline, mainly targeting medicines in earlier stages as it seeks to position itself to develop the next blockbuster medicine. For more, we speak with Michelle Cortez, Bloomberg News Senior Editor for Global Business.